Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir
第一作者单位:[1]Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
推荐引用方式(GB/T 7714):
Sun Jian,Yuan Quan,Xie Qing,et al.Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir[J].HEPATOLOGY.2013,58:701A-701A.
APA:
Sun, Jian,Yuan, Quan,Xie, Qing,Fan, Rong,Tan, Deming...&Hou, Jinlin.(2013).Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir.HEPATOLOGY,58,
MLA:
Sun, Jian,et al."Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir".HEPATOLOGY 58.(2013):701A-701A